These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34625877)

  • 1. Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.
    Lee J; Suh J; Song C; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H
    Ann Surg Oncol; 2022 Apr; 29(4):2473-2479. PubMed ID: 34625877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
    Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
    J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
    Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
    Midenberg E; Higgins MI; Schmeusser BN; Patil DH; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP; Ogan K; Bilen MA; Master VA
    Urol Oncol; 2023 Jan; 41(1):50.e19-50.e26. PubMed ID: 36280529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Sharma P; Zargar-Shoshtari K; Caracciolo JT; Fishman M; Poch MA; Pow-Sang J; Sexton WJ; Spiess PE
    Urol Oncol; 2015 Aug; 33(8):339.e17-23. PubMed ID: 26094169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Sarcopenia Impact Complications and Overall Survival in Patients Undergoing Radical Nephrectomy for Stage III and IV Kidney Cancer?
    Peyton CC; Heavner MG; Rague JT; Krane LS; Hemal AK
    J Endourol; 2016 Feb; 30(2):229-36. PubMed ID: 26418428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS; Ogan K; Master VA
    Cancer; 2022 Jun; 128(11):2073-2084. PubMed ID: 35285950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
    Watanabe S; Ishihara H; Takagi T; Kondo T; Ishiyama R; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Jpn J Clin Oncol; 2021 Apr; 51(5):819-825. PubMed ID: 33558883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma.
    Makino T; Izumi K; Iwamoto H; Kadomoto S; Kadono Y; Mizokami A
    In Vivo; 2023; 37(3):1304-1311. PubMed ID: 37103104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
    Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS; Narayan VM; Bilen MA; Psutka SP; Ogan K; Master VA
    Oncologist; 2023 Dec; 28(12):e1219-e1229. PubMed ID: 37540787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.
    Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W
    World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
    Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
    Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma.
    Fukushima H; Nakanishi Y; Kataoka M; Tobisu K; Koga F
    J Urol; 2016 Jan; 195(1):26-32. PubMed ID: 26292042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
    Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
    PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.